Immunotherapy Clinical Trials in Jinan, Shandong
5 recruitingJinan, Shandong, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Hepatocellular CarcinomaRadiotherapyImmunotherapy+3 more
Shandong Cancer Hospital and Institute54 enrolled1 locationNCT07062055
Recruiting
Phase 2
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Advanced Colorectal CarcinomaImmunotherapy
Fudan University208 enrolled10 locationsNCT06521866
Recruiting
Phase 2
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Cervical CancerNeoadjuvant ChemoimmunotherapyRadical Hysterectomy+1 more
Tongji Hospital50 enrolled2 locationsNCT06289751
Recruiting
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
Carcinoma, HepatocellularImmunotherapy
Qilu Hospital of Shandong University200 enrolled1 locationNCT06571396
Recruiting
Not Applicable
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
Esophageal CancerImmunotherapyGastroesophageal Cancer+1 more
The Second Hospital of Shandong University200 enrolled1 locationNCT04688801